Whole blood rotation thromboelastometry (ROTEM®) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V
- 19 December 2011
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 18 (3) , 463-468
Abstract
Summary. Severe factor V (FV) deficiency (parahaemophilia) is a rare congenital hemorrhagic disorder characterized by very low or undetectable plasma FV levels and bleeding phenotype ranging from mild to severe. We evaluated whole blood (WB) rotation thromboelastometry (ROTEM) in parahaemophilia patients and the contribution of intraplatelets FV, if any, to clot formation. Standard ROTEM® assays were performed in WB from nine parahaemophilia patients and 50 healthy controls. In addition, platelets poor plasma from one parahaemophilia patient (PPP‐Pt) or normal subjects (PPP‐N) was reconstituted with washed platelets obtained either from one patient with parahaemophilia (Plts‐Pt) or normal subjects (Plts‐N) and ROTEM assays were performed in platelets rich plasma (PRP) samples. There was a prolongation of the WB clotting time (CT) in all assays in patients as compared with controls. However, maximum clot firmness (MCF) was similar in patients and controls. ROTEM in PPP‐Pt showed both a prolongation of CT and a reduction of MCF as compared with PPP‐N. The addition of either Plts‐Pt or Plts‐N to PPP‐Pt resulted in similar increase in MCF and a decrease of CT which was more evident for PPP‐Pt + Plts‐N than PPP‐Pt + Plts‐Pt. In contrast, the addition of Plts‐Pt or Plts‐N to PPP‐N had superimposable effects on both CT and MCF. In parahaemophilia patients, WB ROTEM® presents mainly with prolongation of CT and no relevant effect on MCF. Residual intraplatelets FV in parahaemophilia contributes significantly to thrombin generation as shown in artificially reconstituted PRP models.Keywords
This publication has 15 references indexed in Scilit:
- Homozygous F5 deep‐intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet‐rich plasmaJournal of Thrombosis and Haemostasis, 2011
- Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiencyBlood, 2008
- Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosisBlood Coagulation & Fibrinolysis, 2008
- Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patientsThrombosis and Haemostasis, 2008
- How to estimate bleeding risk in mild bleeding disordersJournal of Thrombosis and Haemostasis, 2007
- Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapyHaemophilia, 2006
- Whole blood thrombelastographic coagulation profiles using minimal tissue factor activation can display hypercoagulation in thrombosis‐prone patientsScandinavian Journal of Clinical and Laboratory Investigation, 2006
- Evaluation of the Contribution of Platelets to Clot Strength by Thromboelastography in Rabbits: The Role of Tissue Factor and Cytochalasin DAnesthesia & Analgesia, 2000
- Symptoms of inherited factor V deficiency in 35 Iranian patientsBritish Journal of Haematology, 1998
- Activation of human factor V by factor Xa and thrombinBiochemistry, 1990